E
Evommune, Inc. (EVMN)
NYQ – Real Time Price. Currency in USD
22.69
-0.52 (-2.24%)
At close: May 12, 2026, 4:00 PM EDT
22.00
-0.70 (-3.08%)
Pre-market: May 13, 2026, 4:23 AM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NYQ – Real Time Price. Currency in USD
22.69
-0.52 (-2.24%)
At close: May 12, 2026, 4:00 PM EDT
22.00
-0.70 (-3.08%)
Pre-market: May 13, 2026, 4:23 AM EDT
No Data
There are no news for this stock.
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 8.57 | 6.05 | 10 | |
| Quick ratio | 8.57 | 5.63 | 10 | |
| Debt to Equity | 0.01 | 0.30 | 9.0 | |
| Debt to Assets | 0.01 | 1.04 | 10 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 8.0 | |||
| METRIC | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|
| Total Revenue | 5M | 7M | 13M | 13M |
| Gross Profit | 4M | 6M | 12M | 12M |
| Operating Income | -38M | -70M | -81M | -81M |
| Net Income | -34M | -67M | -69M | -69M |
| EBITDA | -37M | -69M | -80M | -80M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | 86.1 | 5.5 |
| Next quarter | -61.15 | 91.61 | 5.5 |
| Current year | -48.84 | 72.72 | 5.5 |
| Next year | -84.58 | -11.02 | 1.0 |
| Weighted average score | 4.4 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | -99.99 | -126.63 | 82.28 | -72.05 | 3.3 |
| Y/Y | 999 | -77.63 | N/A | 35.93 | 5.5 |
| 3y average | N/A | N/A | N/A | N/A | 1.0 |
| 5y average | N/A | N/A | N/A | N/A | 1.0 |
| Weighted average score | 2.7 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |
Company's cash reserves $44.1M significantly exceed its total debt $2.1M, ensuring strong financial flexibility
Total current assets $153.5M exceed Total current liabilities $17.9M, highlighting excellent liquidity
Debt-to-equity ratio (0.0) is well below the industry average (0.3), showcasing prudent financial management
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$16.8M limits the company's ability to reinvest or pay down debt